Form 4: enGene Holdings Executive Buys Shares
Insider Transaction (Form 4)
William Grossman, Interim Chief Medical Officer and a Director of enGene Holdings Inc., purchased 5,102 shares of common stock on September 22, 2026 for $1.97 per share.
Summary
- Open-market purchase: acquired 5,102 Common Shares at $1.97 ($10,051) on September 22, 2026; holds 5,102 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $10,051, committing personal capital to the stock.
Insider Transactions
William Grossman — Director, Officer (Interim Chief Medical Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-22 | Open-market purchase | Common Shares | 5,102 | $2 | $10.1K | 5,102 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-22 | Open-market purchase (5,102 shares) |
Keywords
insider transaction, Form 4, ENGN, enGene Therapeutics Inc., bullish, William Grossman
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.